Background Annually, 4% of the global population undergoes non-cardiac surgery, with 30% of those patients having at least ...
Slomp Filho, M. (2026) Copyright in Generative Artificial Intelligence. Beijing Law Review, 17, 1-10. doi: ...
FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development ...
In Brazil, the early detection of genetic alterations in lung cancer through liquid biopsies could be a valuable tool for expediting diagnoses and guiding patient treatment.
Formal written minutes from the U.S. FDA confirms no major concerns identified for the planned Phase 3 PANDA study of [68Ga]Ga-PentixaFor in treatment-resistant hypertension and Primary AldosteronismT ...
Learn how the Native American Center for Cancer Health Excellence addresses cancer health disparities through bidirectional ...